# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-278378
Filing Date
2020-10-27
Accepted
2020-10-27 16:02:53
Documents
10
Period of Report
2020-12-16
Effectiveness Date
2020-10-27

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | d17046ddef14a.htm | DEF 14A | 541095
2 | GRAPHIC | g17046dsp2a.jpg | GRAPHIC | 5423
3 | GRAPHIC | g17046g03v42.jpg | GRAPHIC | 1966
4 | GRAPHIC | g17046g1017042551817.jpg | GRAPHIC | 1773
5 | GRAPHIC | g17046g1017042551988.jpg | GRAPHIC | 675
6 | GRAPHIC | g17046g1017042552129.jpg | GRAPHIC | 774
7 | GRAPHIC | g17046g1017042552487.jpg | GRAPHIC | 733
8 | GRAPHIC | g17046g14k01.jpg | GRAPHIC | 265702
9 | GRAPHIC | g17046g16r28.jpg | GRAPHIC | 51363
10 | GRAPHIC | g17046g23q00.jpg | GRAPHIC | 267287
| Complete submission text file | 0001193125-20-278378.txt |  | 1361890

Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 000-50484 | Film No.: 201264151
SIC: 2834 Pharmaceutical Preparations